Gynecology Drugs Market to reach USD 21395.67 Million by 2027
Growing
awareness about women health is driving the growth of Global Gynecology Drugs
Market in the forecast period 2023-2027.
According
to TechSci report on, “Gynecology Drugs Market - Global Industry Size, Share,
Trends, Competition, Opportunities and Forecast, 2017-2027” The global
gynecology drugs market stood at USD14139.56 million in 2021 and is anticipated
to grow at a CAGR of 8.64% in the forecast period. This growth can be
attributed to the increasing incidence of gynecological cancer and
other diseases. Gynecological drugs treat gynecological cancers, menopausal
problems, polycystic ovarian syndrome, contraception, and other illnesses. The global
gynecological drugs market is growing due to rising awareness among females
about various gynecological disorders and their long-term consequences. The key
competitors in the market for gynecological medications are increasingly
interested in expanding their product portfolios and distribution networks.
These efforts suggest that the global gynecological medicines market could grow
from 2017 to 2027.
In the last five years, the fatality rate among women
has risen. As a result, governments worldwide are focused on raising awareness
and warning women about the importance of monitoring their health and
gynecological disorders. These are expected to fuel the market's expansion in
the upcoming years. In addition, market growth is likely to be fueled by
changes in women's lifestyles. As the number of working women in various
industries rises, the risk of infection and sickness due to extended exposure
to dangerous chemicals and toxins is projected to rise, affecting the worldwide
gynecological drugs market.
The increase in the percentage of the elderly female population
is expected to boost the global gynecology drugs market during the forecast
period. As the population of old females increases, they are projected to be
suffering from more gynecological problems. For instance, according to the
World Population Prospects, about 9.5% of females above the age group of 60
years as of 2021, from which most of the female population are susceptible to
gynecological infections or diseases. So, the increased ratio of the old female
population is also enhancing the growth of the gynecology drugs market
worldwide.
There has been an increase in the investment in
gynecological research by major players such as Roche, Pfizer, Merck, and many
others. For instance, in 2019, Merck invested USD125 million in Moderna
Therapeutics to support the company in doing gynecological studies and
developing personalized vaccines and using precision medicine to treat gynecological disorders and diseases. This,
in turn, is expected to support the growth of the global gynecology drugs
market during the forecast period.
Browse over 121 market data Figures and 9 market data
Tables spread through 199 Pages and an in-depth
TOC on “Global
Gynecology Drugs Market”.
https://www.techsciresearch.com/report/gynecology-drugs-market/7427.html
Global gynecology drugs market is segmented by
therapeutics, indication, distribution channel, region, and company. Based on
indication, the market is segmented into contraception, gynecology infections,
female infertility, postmenopausal disorders, polycystic ovary syndrome,
gynecology cancer, and endometriosis. Contraception holds a major revenue share
among the other indications of the increased demand for oral contraceptive
drugs due to their clinical benefits over other traditional drugs. Moreover,
the government in developing countries is also promoting adopting and using
contraceptive drugs to control the rapidly increasing population. Based on the
distribution channel, the market is segmented into retail pharmacies, hospital
pharmacies, and online pharmacies. Online pharmacies showed substantial growth
during the COVID-19 crisis as many consumers shifted towards e-pharmacies to
avoid the risk of infection.
A partial list of leading companies
in the global gynecological drugs market includes:
- Amgen
Inc.
- F.
Hoffmann-La Roche Ltd.
- Novartis
AG
- Bayer
AG
- Merck
& Co., Inc.
- Eli
Lilly and Company
- Pfizer
Inc.
- Abbott
Laboratories
- AbbVie
Inc.
- GlaxoSmithKline
Plc
- AstraZeneca
Plc
- Lupin
Limited
- Johnson
and Johnson
- Sanofi
SA
- Ferring Pharmaceuticals
Download Sample
Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7427
Customers can also
request for 10% free customization on this report.
The
Asia Pacific region is expected to register significant growth in the global
gynecological drugs market during the forecast period. The market is driven by
increasing population and economic development, resulting in the expansion of
the health care sector. Additionally, improving healthcare infrastructure and
increasing initiatives by governments of countries in the region are expected
to influence market growth positively. For instance, the National Rural Health
Mission is an initiative to increase public expenditure on health, thereby
providing better healthcare facilities to females in India. Countries like
China, India, and South Korea focus on generating awareness regarding the
functions and diseases specific to women and girls, especially those affecting
the reproductive system. Besides, high growth in the female population in the
region is likely to create lucrative opportunities for market growth in the
forthcoming years.
New
market players may align themselves with the government authorities to identify
the geographies in urgent need of gynecological drugs in the market. Rural
population requires well-established healthcare system and thus merger &
acquisitions with the global giants to facilitate the infrastructure
development would support their brand establishment in the future market,” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“Gynecology Drugs Market - Global Industry Size, Share, Trends,
Competition, Opportunities and Forecast, 2017-2027 Segmented By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy),
By Indication (Contraception, Gynecology Infections, Female Infertility,
Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology
Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies,
Hospital Pharmacies, Online Pharmacies), By Region”, has evaluated
the future growth potential of global gynecological drugs market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in global gynecology drugs market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]